C
LIVE

Serial Number

79322618

Owner

CHIESI FARMACEUTICI S.P.A.

Attorney

Reed Fryar

Filing Date

Apr 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

C Trademark

Serial Number: 79322618 • Registration: 6805688

C is a trademark filed by CHIESI FARMACEUTICI S.P.A. on April 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CHIESI FARMACEUTICI S.P.A. (100 trademarks)

PARMA , IT

Entity Type: 03

Trademark Details

Filing Date

April 2, 2021

Registration Date

August 2, 2022

Published for Opposition

May 17, 2022

Goods & Services

Scientific and technology services, namely, pharmaceutical drug development services; technological research services in the field of pharmaceutical research and development; scientific research in the field of pharmacy; scientific research relating to biology; scientific research relating to genetics; scientific research and industrial research in the field of pharmaceutical research and development; scientific research and analysis, namely, pharmaceutical research and development; scientific and technological services relating to pharmaceutical drug and nutritional supplements development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; bacteriological research and analysis; biological research and analysis; chemical research and analysis services; clinical research, namely, conducting clinical trials for others; biological research, clinical research in the field of respiratory science and medicine and medical research; industrial analysis and research services in the field of pharmaceutical research; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells

Promotional and advertising services; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical issues; advertising services to promote public awareness of medical conditions; advertising services relating to cosmetics; providing consumer product information relating to cosmetics; retail store services in relation to dietetic preparations; retail store services in relation to pharmaceutical preparations; online retail store services in relation to cosmetics; retail store services in relation to medical instruments; retail store services in relation to medical apparatus; retail store services for a pharmaceutical, veterinary and sanitary preparations and medical supplies

medical apparatus and instruments for treating cardiovascular disease, for treating osteoarthritis, for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; apparatus for administering pharmaceuticals, namely, medical devices for accessing subcutaneous structures of the human body; apparatus for administering drugs by inhalation sold empty; medical ventilators; oxygen inhalators for therapeutic purposes sold empty; infusion pumps to deliver medication; respiratory therapy instruments, namely, sterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold pre-filled with water; medical apparatus for assisting breathing, namely, portable devices used for breathing exercises and for respiratory muscle training; portable nebulisers for medical purposes; ventilator breathing apparatus for artificial respiration; medical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold emptymedical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold empty; respiratory masks for medical purposes; inhalers for medical use, sold empty; nebulizers for respiration therapy; respirators for artificial respiration for medical purposes; apparatus for the alleviation of breathing difficulties, namely, infusion and injection devices; masks and equipment for artificial respiration; oxygenators for medical use; medical apparatus for facilitating the inhalation of pharmaceutical preparations, sold empty; vaporizers for the treatment of upper respiratory conditions; oxygen inhalers for medical use sold empty; diagnostic, examination and monitoring equipment, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; surgical ophthalmic instruments; massage apparatus; dummies for babies; catheters for medical use; apparatus for the regeneration of stem cells for medical purposes; implantable subcutaneous drug delivery devices; prosthetics, namely, ligaments and tissues for vascular use and artificial implant; artificial limbs; orthopedic articles, namely, devices used in orthopedic transplant and/or implant surgery; orthopedic joint implants made of artificial materials; sphygmotensiometers; equipment for diagnosis, examinations and monitoring, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events

Pharmaceuticals for the treatment of diseases of the respiratory system, central nervous system [CNS], the metabolic system, the cardio-vascular system, the musculo-skeletal system, immune system, gastro-intestinal system, endocrine system, or caused by bacteria; Pharmaceuticals for the treatment of autoimmune disorders, viral diseases, skin diseases; pharmaceuticals and natural remedies for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; pharmaceutical compositions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicines for human purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal healthcare preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal preparations and substances for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; biotechnological preparations for medical use for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; stem cells for medical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; medicinal infusions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicated compresses; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for ophthalmological use; pharmaceutical products for ophthalmological use; medicated plasters; transdermal patches for the treatment of diseases of the musculo-skeletal system; transdermal patches for medical treatment of the musculo-skeletal system diseases; liquid vitamin supplements; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; nutraceuticals for use as a dietary supplement; vitamin preparations in the nature of food supplements; dietary supplements consisting of vitamins; nutraceuticals for therapeutic purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; enzyme dietary supplements; vitamin and mineral supplements; disinfectants and antiseptics; viral vaccines

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 2, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 2, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2022 PUBO
NOTIFICATION PROCESSED BY IB
May 16, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 27, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 14, 2022 PREV
ASSIGNED TO LIE
Apr 12, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 22, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 19, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 18, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 14, 2021 REPR